The use of resistance testing in the management of HIV-1-infected patients.
about
Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.HIV-1 diversity after a class switch failure.Development of a simple microarray for genotyping HIV-1 drug resistance mutations in the reverse transcriptase gene in rural Tanzania.Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005.Novel two-round phenotypic assay for protease inhibitor susceptibility testing of recombinant and primary HIV-1 isolates.Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.A simple and cost-saving phenotypic drug susceptibility testing of HIV-1.Comparing Peripheral Blood Mononuclear Cell DNA and Circulating Plasma viral RNA pol Genotypes of Subtype C HIV-1.Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antNext-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics.
P2860
Q33622927-6D7E0027-EE15-4CBA-992F-28AA1A8A1B78Q34399268-1AE38E10-152B-402D-BBD0-36C3B6A8FB7AQ35127150-3A920F39-4112-48C0-983E-322F18CF7E85Q35862295-0A4435E7-6E10-47B1-9779-B2C42ABE0BD5Q35898538-65F80173-C4F8-4BF2-B092-3875D10293ADQ36016153-DC9F00EC-59FB-4F58-B28D-0D503EC797E7Q36414162-B1273745-FEB0-44AE-AF3F-D01C2907DB91Q36933330-C5F4BA95-66DC-43CF-BF06-4BD2962865DCQ37264500-E8F1B498-C8BF-4A22-BCAB-B244E91AB059Q38400774-66DCD6F3-CCED-47D3-A036-2395AD816A7FQ42148219-59604B32-0187-467A-8F13-70250012D95FQ42234370-C9CACF0D-5CB1-498A-A14C-27E6DC2D4376Q42731526-E2D87A41-342F-4A5A-A18C-D86F05AEC4F9
P2860
The use of resistance testing in the management of HIV-1-infected patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The use of resistance testing in the management of HIV-1-infected patients.
@en
The use of resistance testing in the management of HIV-1-infected patients.
@nl
type
label
The use of resistance testing in the management of HIV-1-infected patients.
@en
The use of resistance testing in the management of HIV-1-infected patients.
@nl
prefLabel
The use of resistance testing in the management of HIV-1-infected patients.
@en
The use of resistance testing in the management of HIV-1-infected patients.
@nl
P1476
The use of resistance testing in the management of HIV-1-infected patients.
@en
P2093
Andrew R Zolopa
Philip M Grant
P304
P356
10.1097/COH.0B013E328331C14F
P577
2009-11-01T00:00:00Z